Drug combination could be effective for treatment-resistant gonorrhea

(National Institute for Health Research) Scientists comparing treatments for gonorrhea have identified a drug combination that could be an effective back-up for patients not responding to current therapy. The research team, from University Hospitals Birmingham, found that a treatment of the antibiotic gentamicin with azithromycin worked almost as well as the currently used ceftriaxone for genital gonorrhea.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news

Related Links:

Source: International Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Source Type: research
Though the comparison is a bit apples and oranges between now and 1918, the staggering death toll is tragic in any era.Medscape Medical News
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news
A new report claims better federal government coordination is needed, along with an improved public health infrastructure, more tests, and better data on critical supplies.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
Pediatric Dermatology Part I
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
Esther E. Freeman and Devon E. McMahon
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
BRUCE H. THIERS, MD
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
ELSEVIER
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
DERMATOLOGIC CLINICS
Source: Dermatologic Clinics - Category: Dermatology Authors: Source Type: research
Source: The American Journal of Cardiology - Category: Cardiology Source Type: research
Source: The American Journal of Cardiology - Category: Cardiology Source Type: research
More News: Azithromycin | Ceftriaxone | Hospitals | Infectious Diseases | National Institute for Health Research (NIHR) | Rocephin | Zithromax